Health News

It can take years to diagnose children with psychiatric or attention deficit disorders, forcing them to endure a lot of frustration and suffering. But a new study has found evidence that brain scans, if conducted early, can predict whether a youngster is susceptible to mental health or attention problems down the road.

Drugs that tamp down inflammation in the brain could slow or even reverse the cognitive decline that comes with age. In a publication appearing today in the journal Science Translational Medicine, University of California, Berkeley, and Ben-Gurion University scientists report that senile mice given one such drug had fewer signs of brain inflammation and were better able to learn new tasks, becoming almost as adept as mice half their age.

An important case of the current U.S. Supreme Court term is about Deferred Action for Childhood Arrivals, or DACA — a program that some 700,000 undocumented people depend on for the right to work and protection from deportation — and whether or not it was properly ended by the Trump administration in 2017. The program has been kept in place since then by federal court injunctions. Berkeley Law Dean Erwin Chemerinsky and attorney Ethan Dettmer of Gibson, Dunn and Crutcher’s in San Francisco are key members of the litigation team that won one of the court injunctions, and are currently defending DACA in the Supreme Court. In this Nov. 18 talk, they discuss what it’s like litigating a case like this and the Supreme Court arguments that happened last week.

Teen girls in South Africa face an extraordinary threat of HIV: By the time they reach adulthood, one in four South African girls will have contracted the virus, and most are first infected during adolescence. Experiencing depression puts these girls at even higher risk of HIV infection, reveals analyses led by researchers at the University of California, Berkeley, and based on a longitudinal study led by colleagues at the University of North Carolina and the University of the Witwatersrand, South Africa.

With a $106 million gift from the Weill Family Foundation, UC Berkeley (Berkeley), UC San Francisco (UCSF) and the University of Washington (the UW) have launched the Weill Neurohub, an innovative research network that will forge and nurture new collaborations between neuroscientists and researchers working in an array of other disciplines—including engineering, computer science, physics, chemistry, and mathematics—to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.

Researchers at the University of California, Berkeley, have identified biomarkers — genes and specific brain circuits in mice — associated with a common symptom of depression: lack of motivation. The finding could guide research to find new ways to diagnose and potentially treat individuals suffering from lack of motivation and bring closer the day of precision medicine for psychiatric disorders like depression.

From predicting who will be a repeat offender to who’s the best candidate for a job, computer algorithms are now making complex decisions in lieu of humans. But increasingly, many of these algorithms are being found to replicate the same racial, socioeconomic or gender-based biases they were built to overcome.

UC Berkeley and UCSF to form the UCSF-UC Berkeley Schwab Dyslexia and Cognitive Diversity Center thanks for a $20 million gift to support research on dyslexia and similar neurodevelopmental language-processing disorders, or learning differences.

Next week, UC Berkeley will host the second annual Aging, Research, and Technology Innovation Summit, a daylong event that will gather together researchers, entrepreneurs, policymakers and health care workers to tackle some of the biggest questions in aging research.

Next week, UC Berkeley will host the second annual Aging, Research, and Technology Innovation Summit, a daylong event that will gather together researchers, entrepreneurs, policymakers and health care workers to tackle some of the biggest questions in aging research.

When chemist Rebecca Abergel and her team at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) successfully developed an anti-radiation-poisoning pill in 2014, they hoped it would never have to be used. Designed to remove radioactive contaminants from the body in the event of something horrible, like a nuclear reactor meltdown or, even worse, a nuclear attack, the pill may also double as an anti-gadolinium-toxicity pill for MRI patients injected with commonly used contrast dye.

Organophosphates are among the most commonly used classes of pesticides in the United States, despite mounting evidence linking prenatal exposure to the chemicals to poorer cognition and behavior problems in children. A new study led by University of California, Berkeley, researchers is one of the first to use advanced brain imaging to reveal how exposure to these chemicals in the womb changes brain activity.